SIOC 中文
CJOG
Adv search

Chinese Journal of Organic Chemistry >

2019 , Vol. 39 >Issue 2: 491 - 499

DOI: https://doi.org/10.6023/cjoc201806042

ARTICLE

Synthesis and Cdc25B/PTP1B Inhibitory Activity Evaluation of Novel Acylhydrazone Derivatives Containing Carbazole Moity

  • Li Yingjun ,
  • Wang Siyuan ,
  • Jin Kun ,
  • Gao Lixin ,
  • Sheng Li ,
  • Zhang Nan ,
  • Liu Jihong ,
  • Li Jia
Expand
  • a College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029;
    b State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116012;
    c State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203;
    d Chemistry Analysis & Research Center, Faculty of Chemical, Environmental & Biological Science and Technology, Dalian University of Technology, Dalian 116023

Received date: 2018-06-27

  Revised date: 2018-08-22

  Online published: 2018-09-10

Supported by

Project supported by the Natural Science Foundation of Liaoning Province (No. 20102126).

Fold

Abstract

A series of novel acylhydrazone derivatives 6 containing carbazole moity were synthesized by carbazole and 4-cyanobenzyl chloride as starting materials via multi-step reactions. Their structures were characterized by IR, 1H NMR, 13C NMR spectra and elemental analysis. All synthesized target compounds were evaluated for the inhibitory activities against Cdc25B and PTP1B. The results show that the target compounds display significant inhibitory activities against Cdc25B/PTP1B. Among them, compound 4-((carbazol-9-yl)methyl)-N'-(2-hydroxy-1-naphthalenylmethylene)benzoyl hydrazide (6g) had the highest inhibitory activities against Cdc25B and PTP1B with IC50 values of (2.16±0.38) and (1.06±0.23) μg/mL, respectively. The molecular docking results indicated that the hydrogen bond and hydrophobic interaction formed between compound 6g and Cdc25B/PTP1B enzyme.

Key words： acylhydrazone; carbazole; synthesis; Cdc25B and PTP1B inhibitor; molecular docking

Cite this article

Li Yingjun , Wang Siyuan , Jin Kun , Gao Lixin , Sheng Li , Zhang Nan , Liu Jihong , Li Jia . Synthesis and Cdc25B/PTP1B Inhibitory Activity Evaluation of Novel Acylhydrazone Derivatives Containing Carbazole Moity[J]. Chinese Journal of Organic Chemistry, 2019 , 39(2) : 491 -499 . DOI: 10.6023/cjoc201806042

References

[1] Ommis, V.; Demurtas, M.; Deplano, A.; Balboni, G.; Baldisserotto, A.; Manfredini, S.; Pacifico, S.; Liekens, S.; Balzarini, J. Molecules 2016, 21, 579.
[2] Temirak, A.; Shaker, Y. M.; Ragab, F. A. F.; Ali, M. M.; Soliman, S. M.; Mortier, J.; Wolber, G.; Ali, H. I.; Diwani, H. I. E. Arch. Pharm. Chem. Life Sci. 2014, 347, 291.
[3] Wu, D. Y.; Jin, F. F.; Lu, W. Q.; Zhu, J.; Li, C.; Wang, W.; Tang, Y.; Jiang, H. L.; Huang, J.; Liu, G. X.; Li, J. Chem. Biol. Drug Des. 2012, 79, 897.
[4] Taha, M.; Ismail, N. H.; Jamil, W.; Rashwan, H.; Kashif, S. M.; Sain, A. A.; Adenan, M. I.; Anouar, E. H.; Ali, M.; Rahim, F.; Khan, K. M. Eur. J. Med. Chem. 2014, 84, 731.
[5] Bouhadir, K. H.; Koubeissi, A.; Mohsen, F. A.; El-Harakeh, M. D.; Cheaib, R.; Younes, J.; Azzi, G.; Eid, A. A. Bioorg. Med. Chem. Lett. 2016, 26, 1020.
[6] Uppal, G.; Bala, S.; Kamboj, S.; Saini, M. Pharma Chem. 2011, 3, 250.
[7] He, H.; Xia, H.; Xia, Q.; Ren, Y.; He, H. Bioorg. Med. Chem. 2017, 25, 5652.
[8] Feng, Y. X.; Xue, L. W.; Zhang, C. X. J. Chil. Chem. Soc. 2014, 59, 2555.
[9] Maddela S.; Ajitha M.; Venugopal M.; Maddela R. Int. J. Pharm. Pharm. Sci. 2014, 6, 254.
[10] Kumar, V.; Basavarajaswamy, G.; Rai, M. V.; Poojary, B.; Pai, V. R.; Shruthi, N.; Bhat, M. Bioorg. Med. Chem. Lett. 2015, 25, 1420.
[11] Mentese, E.; Bekircan, O.; Islamoglu, F.; Beris, F. S. Rev. Chim. (Bucharest, Rom.) 2015, 66, 25.
[12] Burgeson, J. R.; Gharaibeh, D. N.; Moore, A. L.; Larson, R. A.; Amberg, S. M.; Bolken, T.; Hruby, D. E.; Dai, D. C. Bioorg. Med. Chem. Lett. 2013, 23, 5840.
[13] Eldehna, W. M.; Fares, M.; Abdel-Aziz, M. M.; Abdel-Aziz, H. A. Molecules 2015, 20, 8800.
[14] Velezheva, V.; Brenman, P.; Ivanov, P.; Kornienko, A.; Lyubimov, S.; Kazarian, K.; Nikonenko, B.; Majorov, K.; Apt, A. Bioorg. Med. Chem. Lett. 2016, 26, 978.
[15] Torre, S. M. D. D. L.; Vázquez C.; González-Chávez, Z.; Yépez-Mulia, L.; Nieto-Meneses, R.; Jasso-Chávez, R.; Saavedra, E.; Hernández-Luis, F. Bioorg. Med. Chem. Lett. 2017, 27, 3403.
[16] Murali, K.; Sparkes, H. A.; Prasad, K. J. R. Eur. J. Med. Chem. 2017, 128, 319.
[17] Sun, L. Q.; Wu, Y. B.; Liu, Y. H.; Chen, X. F.; Hu, L. X. Bioorg. Med. Chem. Lett. 2017, 27, 261.
[18] Kato, A.; Nagatsuka, Y.; Hitratsuka, T.; Kiuchi, S.; Iwase, Y.; Okuno, Y.; Tsukamoto, T.; Kiran, Y. B.; Sakai, N.; Konakahara, T. Tetrahedron 2016, 72, 4258.
[19] Mahapatra, D. K.; Das, D.; Shivhare, R. Int. J. Pharm. Sci. Drug Res. 2017, 9, 139.
[20] Itoh, T.; Hatae, N.; Nishiyama, T.; Choshi, T.; Hibino, S.; Yoshimura, T.; Ishikura, M. Med. Chem. Res. 2017, 128, 319.
[21] Arun, A.; Patel, O. P. S.; Saini, D.; Yadav, P. P.; Konwar, R. Biomed. Pharmacother. 2017, 93, 510.
[22] Wang, G. C.; Wang, J.; He, D. X.; Li, X.; Li, J.; Peng, Z. Y. Bioorg. Med. Chem. Lett. 2016, 26, 2806.
[23] Iqbal, S.; Khan, M. A.; Javaid, K.; Sadiq, R.; Fazal-ur-Rehman, S.; Choudhary, M. I.; Basha, F. Z. Bioorg. Chem. 2017, 74, 72.
[24] Börger, C.; Brütting, C.; Julich-Gruner, K. K.; Hesse, R.; Kumar, P.; Kutz, S. K.; Rönnefahrt, M.; Thomas, C.; Wan, B. J.; Franzblau, S. G. Bioorg. Med. Chem. 2017, 25, 6167.
[25] Chirke, S. S.; Krishna, J. S.; Rathod, B. B.; Bonam, S. R.; Khedkar, V. M.; Rao, B. V.; Kumar, H. M. S.; Shetty, P. R. Med. Chem. Drug Discovery 2017, 2, 7309.
[26] Kong, X. Q.; Zhang, H. Z.; Cao, C. S.; Zhou, S. L.; Pang, G. S.; Shi, Y.-H. Bioorg. Med. Chem. 2016, 24, 1376.
[27] Sadiq, Z.; Akbar, E.; Naz, A. N. Int. J. Pharma Bio Sci. 2014, 5, 455.
[28] Salih, N.; Salimon, J.; Yousif, E. Arabian J. Chem. 2016. 9, S781.
[29] Wang, P.-Y.; Fang, H.-S.; Shao, W.-B.; Zhou, J.; Chen, Z.; Song, B.-A.; Yang, S. Bioorg. Med. Chem. Lett. 2017, 27, 4294.
[30] Clausen, J. D.; Kjellerup, L.; Cohrt, K. O.; Hansen, J. B.; Dalby-Brown, W.; Winther, A. M. Bioorg. Med. Chem. Lett. 2017, 27, 4564.
[31] Wang, W. S.; Li, Q.; Wei, Y. F.; Xue, J.; Sun, X.; Yu, Y.; Chen, Z.; Li, S. Z.; Duan, L.-P. Int. J. Parasitol.:Drugs Drug Resist. 2017, 7, 191.
[32] Wang, W. S.; Li, J.; Yao, J. M.; Wang, T.; Li, S. Z.; Zheng, X. T.; Duan, L. P.; Zhang, W.-B. J. Antimicrob. Chemother. 2017, 72, 3122.
[33] Rostom, S. A. F.; Badr, M. H.; Razik, H. A. A. E.; Ashour, H. M. A. Eur. J. Med. Chem. 2017, 139, 263.
[34] Sarkis, M.; Miteva, M. A.; Lang, M. C. D.; Jaouen, M.; Sari, M. A.; Galcéra, M. O.; Ethève-Quelquejeu, M.; Garbay, C.; Bertho, G.; Braud, E. Proteins:Struct., Funct., Bioinf. 2013, 21, 7165.
[35] Lavecchia, A.; Cosconati, S.; Limongelli, V.; Novellino, E. ChemMedChem 2006, 1, 540.
[36] Wang, G. C.; Chen, M.; Qiu, J.; Xie, Z. Z.; Cao, A. B. Bioorg. Med. Chem. Lett. 2018, 28, 113.
[37] Lavecchia, A.; Coluccia, A.; Giovanni, C. D.; Novellino, E. Anticancer Agents Med. Chem. 2008, 8, 843.
[38] Ge, Y.; Kamp, M. V. D.; Malaisree, M.; Liu, D.; Liu, Y.; Mulholland, A. J. J. Comput.-Aided Mol. Des. 2017, 31, 995.
[39] Cai, J. Y.; Zhao, L.; Tao, W. Y. Pharm. Biol. 2015, 53, 1030.
[40] Li, Y. J.; Yu, Y.; Jin, K.; Gao, L. X.; Luo, T. C.; Sheng, L.; Shao, X.; Li, J. Bioorg. Med. Chem. Lett. 2014, 24, 4125.
[41] Li, Y.-J.; Shi, X.-L.; Gao, L.-X.; Jin, K.; Sheng, L.; Wu, J.-H.; Peng, L.-N.; Li, J. Chin. J. Org. Chem. 2015, 35, 191(in Chinese). (李英俊, 史相玲, 高立信, 靳焜, 盛丽, 吴疆红, 彭丽娜, 李佳, 有机化学, 2015, 35, 191.)
[42] Li, Y.-J.; Yu, Y.; Jin, K.; Gao, L.-X.; Luo, T.-C.; Sheng, L.; Shao, X.; Li, J. Chin. J. Org. Chem. 2015, 35, 129(in Chinese). (李英俊, 于洋, 靳焜, 高立信, 罗潼川, 盛丽, 邵欣, 李佳, 有机化学, 2015, 35, 129.)
[43] Li, Y.-J.; Li, J.-Y.; Peng, L.-N.; Gao, L.-X.; Jin, K.; Sheng, L.; Zhang, N.; Wang, S.-Y.; Li, J. Chin. J. Org. Chem. 2017, 37, 485(in Chinese). (李英俊, 李继阳, 彭丽娜, 高立信, 靳焜, 盛丽, 张楠, 王思远, 李佳, 有机化学, 2017, 37, 485.)
[44] Li, Y.-J.; Wang, S.-Y.; Jin, K.; Gao, L.-X.; Sheng, L.; Zhang, N.; Yang, K.-D.; Zhao, Y.; Li, J. Chin. J. Org. Chem. 2018, 38, 1242(in Chinese). (李英俊, 王思远, 靳焜, 高立信, 盛丽, 张楠, 杨凯栋, 赵月, 李佳, 有机化学, 2018, 38, 1242.)
[45] Kahveci, B.; Y?lmaz, F.; Mente?e, E.; Özil, M.; Karao?lu, ?. A. J. Heterocycl. Chem. 2014, 51, 982.
[46] Bayrak, H.; Demirbas, A.; Karaoglu, S. A.; Demirbas, N. Eur. J. Med. Chem. 2009, 44, 1057.
[47] Zhou, M.; Eun, Y. J.; Guzei, I. A.; Weibel, D. B. ACS Med. Chem. Lett. 2013, 4, 880.
[48] Li, Y.-J.; Li, J.-Y.; Jin, K.; Cao, X. Chin. J. Magn. Reson. 2017, 34, 25(in Chinese). (李英俊, 李继阳, 靳焜, 曹欣, 波谱学杂志, 2017, 34, 25.)
[49] Li, Y.-J.; Li, J.-Y.; Xu, Y.-T.; Jin, K.; Cao, X. Chin. J. Org. Chem. 2017, 37, 896(in Chinese). (李英俊, 李继阳, 许永廷, 靳焜, 曹欣, 有机化学, 2017, 37, 896.)
[50] Guo, D. C.; Li, P. L.; Wang, X.; Wang, L. Y.; Wu, P. L. Synth. Commun. 2010, 40, 3315.
[51] Li, Y.-J.; Sun, S.-Q. Semimicro Organic Chemistry Experiment, Chemical Industry Press, Beijing, 2009, pp. 114~115(in Chinese). (李英俊, 孙淑琴, 半微量有机化学实验, 化学工业出版社, 北京, 2009, pp. 114~115.)
[52] Li, Y.-J.; Zhang, N.; Jin, K.; Xu, Y.-T.; Wang, S.-Y.; Zhou, X.-X. Chin. J. Org. Chem. 2017, 37, 2640(in Chinese). (李英俊, 张楠, 靳焜, 许永廷, 王思远, 周晓霞, 有机化学, 2017, 37, 2640.)
[53] Huang, W. G.; Jiang, Y. Y.; Li, Q.; Li, J.; Li, J. Y.; Lu, W.; Cai, J. C. Tetrahedron 2005, 61, 1863.
[54] Sun, L. P.; Shen, Q.; Piao H. H.; Ma, W. P.; Gao, L. X.; Zhang, W.; Nan, F. J.; Li, J.; Piao, H. R. Eur. J. Med. Chem. 2011, 46, 3630.

Options
Outlines

/

〈 〉